The Oticon More is a premium behind-the-ear prescription hearing aid that earned an A grade in HearAdvisor's lab testing, placing it among the top performers in its category. At $4,898, it sits in the highest price tier and competes directly with flagship devices from Phonak, Signia, and Widex.
In our testing, the More demonstrated exceptional speech clarity performance. Its speech in quiet scores measured well above the category average, and speech in noise performance was similarly strong—a meaningful advantage for users who frequently navigate challenging listening environments like restaurants or social gatherings. These strengths contributed to the More earning HearAdvisor's Expert's Choice Award in both 2023 and 2024.
The device does show some limitations worth noting. Music streaming quality measured slightly below the category average, and feedback handling in the tuned fit condition was a weakness, scoring well below average when pushed to meet prescriptive targets. Users who prioritize streaming audio or require aggressive gain settings should weigh these factors.
The Oticon More is best suited for individuals seeking strong speech understanding performance and who value the flexibility of both rechargeable and disposable battery options. It supports streaming to both iPhone and Android devices with hands-free capability. While newer models like the Oticon Intent have since launched with marginally higher scores, the More remains a competitive choice in the premium prescription category.
